About this trial
Mental disorders are often accompanied by health-risk behaviours, psychiatric comorbidity, and reduced functioning. TORCH investigates transdiagnostic mechanisms underlying multiple health behaviour change in adult psychiatric patients, with a focus on nicotine dependence and smoking. Based on the Compensatory Carry-Over Action Model (CCAM), the project examines self-efficacy, motivation, stress regulation, coping, and social support in relation to psychiatric symptoms and rehabilitation outcomes. Using a multimethod, naturalistic observational design, quantitative and qualitative data will be collected in inpatient and day-care psychiatry to identify mechanisms that support health behaviour change and rehabilitation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
The study includes adults with nicotine dependence receiving inpatient or day-care psychiatric treatment at the Department of Psychiatry and Psychotherapy, Kreiskrankenhaus Prignitz. Eligibility requires informed consent and sufficient German language proficiency, with exclusion of individuals whose acute clinical condition or impaired decisional capacity would preclude participation.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
person-centred interventions
BehavioralThe clinic treatment is a person-centred interventions that support smoking cessation, health promotion, rehabilitation participation, and long-term recovery among individuals with mental disorders.
Treatment groups
Trial outcomes
Primary outcomes
BIS-15
Barratt Impulsiveness Scale (BIS) is measuring behavioral inhibition (On a scale of 1 to 4: 1-rarely/never, 2-occasionally, 3-often, 4-almost always/always).
FEVER
Fragebogen zur Erfassung der Veränderungsbereitschaft (FEVER) is measuring readiness to hange / change motivation. On a scale of 1 to 5: 1-not at all applicable, 2-rather not applicable, 3-don't know/undecided, 4-rather applicable, 5-fully applicable.
F-SozU K-14
F-SozU K-14 is a Social Support Questionnaire. On a scale of 1 to 5: 1-not applicable, 2-rather not applicable, 3-partly applicable, 4-applicable, 5-exactly applicable.
Fagerström Test
Fagerström Test is measuring smoking behavior. Higher values mean higher consumption.
Secondary outcomes
SF12
SF12 is measuring functional status (description can be found here: Singh, A., Gnanalingham, K., Casey, A., \& Crockard, A. (2006). Quality of life assessment using the Short Form-12 (SF-12) questionnaire in patients with cervical spondylotic myelopathy: comparison with SF-36. Spine, 31(6), 639-643.).
BSI-18
BSI-18 Is a Brief-Symptom Inventory. On a scale of 1 to 4: 1-not at all, 2, 3, 4-very strongly.
BIP-Q
BIP-Q is measuring the illness perceptions. On a scale of 0 to 10: 0-no impairment at all, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10-very severe impairment.
PSS
PSS is measuring perceived stress. On a scale of 1 to 5: 1-never, 2-almost never, 3-sometimes, 4-quite often, 5-very often.
Other outcomes
Rehabilitation Intentions
Rehabilitation Intentions is measuring Rehabilitation-related intentions and willingness to apply for medical rehabilitation were assessed using self-report items.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Jacobs University Bremen gGmbH
Lead sponsor
Kreiskrankenhaus Prignitz gGmbH
Collaborator
Hamburg University of Applied Sciences
Collaborator
This trial is not recruiting at the moment. You can still explore other options: